Baldness, premature greying may up heart disease risk: study

Image
Press Trust of India Kolkata
Last Updated : Nov 30 2017 | 5:05 PM IST
Men below 40 years of age who are going bald and dealing with premature greying are at five-fold risk of developing heart disease, a study warns.
The study, presented at the 69th Annual Conference of the Cardiological Society of India (CSI) in Kolkata, included 790 men aged less than 40 years with coronary artery disease and 1,270 age-matched healthy men who acted as a control group.
The researchers found that young men with coronary artery disease had a higher prevalence of premature greying (50 per cent versus 30 per cent) and male-pattern baldness (49 per cent versus 27 per cent) compared to healthy controls.
After adjusting for age and other cardiovascular risk factors, male-pattern baldness was associated with a 5.6 times greater risk of coronary artery disease and premature greying was associated with a 5.3 times greater risk.
"The incidence of coronary artery disease in young men is increasing but cannot be explained by traditional risk factors," said author Sachin Patil, from the UN Mehta Institute of Cardiology and Research Centre in Gujarat.
"Premature greying and androgenic alopecia (male-pattern baldness) correlate well with vascular age irrespective of chronological age and are plausible risk factors for coronary artery disease," Patil said.
Male-pattern baldness and premature greying were the strongest predictors of coronary artery disease in young men followed by obesity, which was associated with a 4.1 times greater risk.
Diabetes mellitus, hypertension, family history of premature coronary artery disease, central obesity, higher body mass index, dyslipidaemia and smoking were predictors of coronary artery disease but to a lesser extent than male- pattern baldness, premature greying, and obesity.
"Baldness and premature greying should be considered risk factors for coronary artery disease. These factors may indicate biological, rather than chronological, age which may be important in determining total cardiovascular risk," said Kamal Sharma, from the UN Mehta Institute of Cardiology and Research Centre.
"Currently physicians use common sense to estimate biological age but a validated scale is needed," Sharma said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 30 2017 | 5:05 PM IST

Next Story